Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients (Q63594223)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients |
clinical trial |
Statements
DEFENCE (English)
0 references
Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients- a Randomized, Placebo Controlled Phase II Trial "DEFENCE" (DEnosumab For the rEductioN of the Smoldering Myeloma transformatioN inCidence ratE) (English)
0 references
January 2019
0 references
July 2024
0 references
164
0 references
18 year
0 references